70c valuation/strong buy, page-12

re: 70c valuation/ocker Ocker,
As I told you a few months ago, on the basis of information available at the time I wrote that 2003 post you cite, my analysis was more or less correct, and the shareprice rose 20% in the weeks following that old post. From memory, I sold at 92c.

There is no denying that 2004 was a disaster for most ADA shareholders (I saw the fall coming and got out early, hence the long gaps between my posts). But a horrible year is often followed by an excellent year, at least for shareholders who know how to read a balance sheet and who have a good instinct for timing the turn-around.

Its easy to criticise someone who makes a recommendation against the trend, but why don't you follow up on my research? You might find that my recommendation/valuation is in fact realistic.

For what it's worth, here is a summary of my other public recommendations (on HC and SS) over the last 18 months:
PHY, Long term buy at $2.70, now trading at $4.50 (in my last post on SS before the takeover price was announced, I predicted $4.50)
QRS, Buy at 14c, Sell at 28c; The stock hit 32c a week after my sell recommendation, and is now trading at 12c.
ANP, Sell at 14c. Now trading at 6c
ABI, Buy at 20c, sell at 45c, buy again at 30c, sell at 27c.
ERG, Buy at 27c
CMQ, Short term buy at 1.22, sell after APVMA license announcement. Buy back in under $1.

Predicting the future of a stock is an uncertain art, but I think my record shows that I'm right far more often than I'm wrong. Time will tell re Adacel.